Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 13, 2018
Cambrex has completed the acquisition of Halo Pharma, a dosage form CDMO located in Whippany, New Jersey and Mirabel, Québec, Canada, for approximately $425 million.
read more
Thursday, September 13, 2018
Particle Sciences has announced the appointment of Dr. Robert Lee to president.
read more
Thursday, September 13, 2018
CytRx has received a milestone payment of $250,000 from Orphazyme A/S.
read more
Thursday, September 13, 2018
Mitra Biotech announced a partnership with Glenmark Pharmaceuticals focused on advancing Glenmark's proprietary immuno-oncology drug pipeline utilizing Mitra's CANscript platform.
read more
Friday, September 14, 2018
Nephron Pharmaceuticals is currently producing medications at its West Columbia, S.C. facility while monitoring the effects of Hurricane Florence.
read more
Friday, September 14, 2018
Natera announced an agreement with Bristol-Myers Squibb to use Natera's Signatera custom circulating tumor DNA assay in a Phase 2 study in the adjuvant non-small cell lung cancer setting.
read more
Monday, September 17, 2018
RXTransparent has been awarded a contract with Minnesota Multistate Contracting Alliance for Pharmacy for FDA DSCSA Compliance Solutions.
read more
Monday, September 17, 2018
Nemaura Pharma has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.
read more
Monday, September 17, 2018
PAREXEL and Datavant announced they are partnering to enhance clinical study design and operations, as well as the generation of real-world evidence.
read more
Monday, September 17, 2018
Samumed has entered an exclusive license agreement with United Therapeutics for North American rights to Samumed's SM04646, being developed for the treatment of idiopathic pulmonary fibrosis.
read more
Monday, September 17, 2018
Isotopen Technologien München (ITM) has signed a Research Evaluation and Option Agreement for a worldwide exclusive license with Merck KGaA, Darmstadt, Germany.
read more
Monday, September 17, 2018
PCI Pharma Services announced its exclusive collaboration agreement with CSP Technologies for U.S. clinical trials and stability testing utilizing Activ-Blister packaging solutions.
read more
Tuesday, September 18, 2018
PharmaCyte Biotech announced its partner, Austrianova, has successfully performed an additional pre-production “engineering run” using the Cell-in-a-Box encapsulated cells that will be used, in combination with low doses of the cancer prodrug ...
read more
Tuesday, September 18, 2018
Aphena Pharma Solutions has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations.
read more
Tuesday, September 18, 2018
Integral Molecular and Merus N.V. announced they have entered into a collaboration on multiple undisclosed targets.
read more